MDT [NYSE]
Medtronic plc
IndexS&P 500 P/E28.58 EPS (ttm)3.63 Insider Own0.23% Shs Outstand1.34B Perf Week4.25%
Market Cap137.15B Forward P/E17.80 EPS next Y5.83 Insider Trans-0.31% Shs Float1.34B Perf Month-4.78%
Income4.91B PEG2.35 EPS next Q1.57 Inst Own83.60% Short Float0.74% Perf Quarter1.47%
Sales31.79B P/S4.31 EPS this Y-26.10% Inst Trans0.44% Short Ratio1.66 Perf Half Y-12.99%
Book/sh39.10 P/B2.65 EPS next Y2.97% ROA5.30% Target Price124.18 Perf Year-17.30%
Cash/sh8.49 P/C12.22 EPS next 5Y12.17% ROE9.50% 52W Range98.38 - 135.89 Perf YTD0.35%
Dividend2.52 P/FCF58.19 EPS past 5Y0.80% ROI4.90% 52W High-23.61% Beta0.74
Dividend %2.43% Quick Ratio2.10 Sales past 5Y0.90% Gross Margin68.50% 52W Low5.52% ATR2.52
Employees90000 Current Ratio2.60 Sales Q/Q-0.20% Oper. Margin17.90% RSI (14)46.03 Volatility2.04% 2.40%
OptionableYes Debt/Eq0.48 EPS Q/Q17.00% Profit Margin15.50% Rel Volume0.62 Prev Close102.67
ShortableYes LT Debt/Eq0.46 EarningsMay 26 BMO Payout67.60% Avg Volume5.93M Price103.81
Recom2.00 SMA20-1.65% SMA50-3.40% SMA200-9.41% Volume3,751,212 Change1.11%
Apr-13-22Downgrade Truist Buy → Hold $124 → $121
Mar-02-22Resumed BofA Securities Buy $135
Jan-10-22Downgrade BTIG Research Buy → Neutral
Jan-07-22Downgrade Morgan Stanley Overweight → Equal-Weight $145 → $120
Jan-04-22Downgrade Piper Sandler Overweight → Neutral $152 → $110
Dec-17-21Downgrade JP Morgan Overweight → Neutral $130 → $105
Dec-16-21Downgrade Wells Fargo Overweight → Equal Weight $137 → $110
Dec-10-21Initiated RBC Capital Mkts Outperform $140
Jun-10-21Resumed Cowen Outperform $141
May-25-21Initiated Barclays Equal Weight $145
Apr-15-21Initiated Atlantic Equities Overweight $153
Dec-15-20Upgrade Morgan Stanley Equal-Weight → Overweight $140
Dec-15-20Upgrade Goldman Sell → Neutral $100 → $119
Oct-08-20Upgrade Stifel Hold → Buy $125
Oct-08-20Upgrade Bernstein Mkt Perform → Outperform
Sep-11-20Initiated Wolfe Research Peer Perform $115
May-14-20Downgrade DZ Bank Buy → Hold $92
Mar-30-20Downgrade Needham Strong Buy → Buy $134 → $109
Mar-25-20Upgrade DZ Bank Hold → Buy $90
Mar-05-20Initiated Citigroup Buy $124
May-16-22 03:33PM  
11:50AM  
May-15-22 05:37PM  
May-13-22 12:08PM  
08:00AM  
06:45AM  
06:45AM  
12:00AM  
May-12-22 08:14AM  
07:45AM  
May-11-22 06:00PM  
05:55PM  
May-10-22 11:11AM  
May-06-22 11:11AM  
May-05-22 06:00PM  
11:01AM  
08:15AM  
Apr-28-22 05:45PM  
10:45AM  
10:00AM  
10:00AM  
08:01AM  
05:50AM  
Apr-27-22 05:50PM  
04:37PM  
09:31AM  
Apr-26-22 12:34PM  
Apr-25-22 04:10PM  
Apr-21-22 05:50PM  
Apr-20-22 11:58AM  
08:50AM  
Apr-18-22 07:38AM  
Apr-15-22 09:36AM  
Apr-13-22 05:50PM  
05:31PM  
Apr-11-22 12:09PM  
Apr-08-22 02:14PM  
08:02AM  
Apr-07-22 05:50PM  
Apr-06-22 04:01PM  
10:15AM  
Apr-05-22 09:30AM  
09:09AM  
07:46AM  
Apr-04-22 04:10PM  
01:00PM  
Apr-02-22 08:54AM  
Apr-01-22 05:50PM  
Mar-30-22 11:00AM  
Mar-29-22 01:40PM  
12:51AM  
Mar-28-22 09:11AM  
Mar-25-22 07:00AM  
Mar-24-22 01:30PM  
11:30AM  
11:12AM  
Mar-23-22 07:02PM  
03:42PM  
12:16PM  
10:00AM  
Mar-22-22 02:16PM  
Mar-21-22 02:02PM  
11:46AM  
Mar-18-22 02:04PM  
09:40AM  
07:50AM  
Mar-17-22 04:32PM  
10:30AM  
08:30AM  
08:30AM  
Mar-16-22 08:00AM  
Mar-15-22 08:42AM  
Mar-10-22 02:31PM  
12:31PM  
09:10AM  
Mar-09-22 03:05PM  
11:56AM  
10:53AM  
08:00AM  
Mar-07-22 04:11PM  
08:47AM  
08:00AM  
Mar-04-22 02:46PM  
01:16PM  
06:45AM  
Mar-03-22 11:10AM  
Mar-02-22 03:53PM  
12:01PM  
Mar-01-22 02:16PM  
11:36AM  
Feb-28-22 11:00AM  
08:00AM  
Feb-23-22 09:46AM  
06:16AM  
Feb-22-22 04:02PM  
02:42PM  
12:21PM  
10:57AM  
10:50AM  
10:30AM  
Medtronic plc develops, manufactures, distributes, and sells device-based medical therapies to hospitals, physicians, clinicians, and patients worldwide. It operates through four segments: Cardiovascular Portfolio, Neuroscience Portfolio, Medical Surgical Portfolio, and Diabetes Operating Unit. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; AF ablation products; insertable cardiac monitor systems; mechanical circulatory support; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves; percutaneous coronary intervention stents, surgical valve replacement and repair products, endovascular stent grafts, percutaneous angioplasty balloons, and products to treat superficial venous diseases in the lower extremities. The Medical Surgical Portfolio segment offers surgical products, including surgical stapling devices, vessel sealing instruments, wound closure, electrosurgery products, surgical artificial intelligence and robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology and lung products, and various therapies to treat diseases. The Neuroscience Portfolio segment offers products for spinal surgeons; neurosurgeons; neurologists; pain management specialists; anesthesiologists; orthopedic surgeons; urologists; urogynecologists; interventional radiologists; ear, nose, and throat specialists; and systems that incorporate energy surgical instruments. It also provides image-guided surgery and intra-operative imaging systems and robotic guidance systems used in robot assisted spine procedures; and therapies for vasculature in and around the brain. The Diabetes Operating Unit segment offers insulin pumps and consumables, and continuous glucose monitoring systems. The company was founded in 1949 and is headquartered in Dublin, Ireland.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
PARKHILL KAREN LEVP & Chief Financial OfficerMar 18Sale110.0068275,02034,946Mar 21 07:34 PM
Surface Carol ASVP, Chief HR OfficerMar 11Sale105.306,000631,80028,502Mar 14 05:46 PM
WHITE ROBERT JOHNEVP & Pres. Medical SurgicalDec 23Sale102.047,218736,52539,430Dec 27 06:31 PM
ANDERSON RICHARD HDirectorDec 16Buy103.265,010517,333108,374Dec 17 04:57 PM
PARKHILL KAREN LEVP & Chief Financial OfficerDec 06Sale110.0068275,02035,446Dec 07 06:23 PM
Lerman Bradley ESVP General Counsel & Corp SecSep 30Option Exercise78.0049,1473,833,46697,910Oct 01 06:13 PM
Lerman Bradley ESVP General Counsel & Corp SecSep 30Sale126.5849,1476,221,02748,763Oct 01 06:13 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 31Option Exercise74.8450,7753,800,00199,538Sep 01 05:27 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 31Sale134.1750,7756,812,48248,763Sep 01 05:27 PM
Martha GeoffreyCEOAug 25Option Exercise61.8111,581715,805105,936Aug 26 07:26 PM
Salmon SeanEVP & Pres Diabetes/CardiovascAug 25Option Exercise38.7128,4191,100,06654,458Aug 26 07:28 PM
Martha GeoffreyCEOAug 25Sale132.6711,5811,536,45195,836Aug 26 07:26 PM
Salmon SeanEVP & Pres Diabetes/CardiovascAug 25Sale134.0828,4193,810,49233,329Aug 26 07:28 PM
Lerman Bradley ESVP General Counsel & Corp SecAug 02Sale131.524,000526,08048,194Aug 04 06:18 PM
Martha GeoffreyCEOJun 28Option Exercise55.3211,500636,18093,448Jun 30 06:21 PM
Martha GeoffreyCEOJun 28Sale125.2911,5001,440,83581,948Jun 30 06:21 PM
Wall Brett A.EVP & Pres NeuroscienceJun 21Sale123.5011514,20221,602Jun 22 05:58 PM
Wall Brett A.EVP & Pres NeuroscienceJun 18Option Exercise74.841,16887,41322,655Jun 22 05:58 PM
PARKHILL KAREN LEVP & Chief Financial OfficerJun 15Sale124.4760575,30486,223Jun 17 06:11 PM
Wall Brett A.EVP & Pres NeuroscienceJun 01Sale128.072,473316,71721,487Jun 02 06:00 PM
Liddicoat John REVP & President of AmericasMay 28Option Exercise82.7334,6562,866,92577,207Jun 01 05:55 PM
Wall Brett A.EVP & Pres NeuroscienceMay 28Option Exercise47.0012,300578,10031,315Jun 02 06:00 PM
Liddicoat John REVP & President of AmericasMay 28Sale126.6534,6564,389,18242,551Jun 01 05:55 PM